Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Index
-
Market Cap
1.06B
Enterprise Value
2.49B
Income
49.65M
Sales
279.31M
Book/sh
15.69
Cash/sh
0.58
Employees
-
IPO
Jun 12, 2008
P/E
21.34
Forward P/E
8.77
PEG
-
P/S
3.79
P/B
0.77
P/C
20.67
P/FCF
84.64
EV/EBITDA
15.57
EV/Sales
8.92
Quick Ratio
0.24
Current Ratio
0.24
Debt/Eq
1.07
LT Debt/Eq
0.76
Option/Short
Yes / Yes
EPS (ttm)
0.56
EPS next Y
1.37
EPS next Q
0.36
EPS this Y
-15.52%
EPS next Y
-8.23%
EPS next 5Y
-8.13%
EPS past 3/5Y
-6.44% -13.94%
Sales past 3/5Y
2.33% 18.33%
EPS Y/Y TTM
338.26%
Sales Y/Y TTM
25.84%
EPS Q/Q
49.18%
Sales Q/Q
-32.63%
Insider Own
0.45%
Insider Trans
1.15%
Inst Own
41.88%
Inst Trans
-
ROA
1.66%
ROE
3.48%
ROIC
2.04%
Gross Margin
86.28%
Oper. Margin
57.27%
Profit Margin
17.78%
SMA20
1.90%
SMA50
0.30%
SMA200
-3.50%
Trades
Shs Outstand
88.09M
Shs Float
87.69M
52W High
14.72 -18.25%
52W Low
10.59 13.54%
Volatility
1.95% 2.27%
ATR (14)
0.27
RSI (14)
54.09
Beta
0.55
Rel Volume
0.58
Avg Volume
848.91K
Volume
495,994
Perf Week
2.91%
Perf Month
2.20%
Perf Quarter
5.97%
Perf Half Y
-5.26%
Perf YTD
-5.26%
Perf Year
-14.22%
Perf 3Y
-37.43%
Perf 5Y
-39.00%
Perf 10Y
-18.46%
Prev Close
12.20
Price
12.03
Change
-1.39%
Date Action Analyst Rating Change Price Target Change
May-13-25Resumed B. Riley Securities Neutral $14
Dec-11-24Downgrade B. Riley Securities Neutral → Sell $15
Nov-20-24Downgrade JP Morgan Overweight → Neutral $17 → $15
Nov-19-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Aug-26-24Downgrade Wells Fargo Overweight → Equal Weight $18 → $17
Aug-02-24Downgrade Oppenheimer Outperform → Perform
Feb-02-24Downgrade Keefe Bruyette Outperform → Mkt Perform $22 → $19
Jan-08-24Downgrade B. Riley Securities Buy → Neutral $21
Aug-04-23Downgrade Hovde Group Outperform → Market Perform $21
Oct-14-22Initiated B. Riley Securities Buy $6.25
May-06-26 03:50PM
03:44PM
08:30AM
May-05-26 06:13AM
06:00AM
11:09AM Loading…
Apr-17-26 11:09AM
Apr-02-26 04:57PM
Feb-11-26 12:39AM
Feb-06-26 05:30AM
Feb-05-26 12:32AM
Feb-04-26 08:28PM
06:00PM
12:10PM
07:10AM
06:33AM
06:06AM Loading…
06:06AM
06:00AM
Feb-02-26 10:05PM
Jan-29-26 08:05AM
Jan-08-26 10:31PM
Jan-05-26 04:00PM
Nov-25-25 12:31AM
Nov-19-25 12:31AM
Nov-18-25 06:00PM
07:15AM
06:23AM
06:00AM
Nov-16-25 10:01PM
Nov-13-25 07:35PM
Nov-12-25 06:10PM
11:33PM Loading…
Oct-19-25 11:33PM
Oct-10-25 09:35AM
Oct-07-25 05:00PM
Aug-18-25 01:00PM
Aug-06-25 03:23AM
Aug-05-25 07:15AM
06:09AM
06:00AM
Aug-04-25 09:42AM
Jul-14-25 07:15AM
Jul-02-25 04:00PM
May-04-25 08:42AM
May-02-25 03:14AM
01:38AM
May-01-25 02:01PM
07:10AM
06:07AM
06:00AM
Apr-30-25 09:15AM
Apr-29-25 10:01AM
Apr-25-25 08:30AM
Apr-24-25 09:15AM
Apr-21-25 07:31PM
Apr-19-25 11:44AM
Apr-18-25 07:28AM
Apr-14-25 05:05PM
Apr-10-25 05:01AM
Apr-02-25 09:15AM
Apr-01-25 04:05PM
Mar-31-25 09:15AM
Mar-26-25 03:08PM
Mar-21-25 09:15AM
Mar-19-25 04:05PM
Feb-20-25 04:30PM
Feb-05-25 02:54AM
02:13AM
Feb-04-25 07:20AM
06:18AM
06:00AM
Feb-03-25 07:07AM
Jan-02-25 04:05PM
Dec-13-24 08:30PM
Nov-21-24 05:00AM
Nov-20-24 02:41AM
02:04AM
Nov-19-24 09:30AM
07:15AM
06:22AM
06:00AM
Nov-18-24 10:22PM
Oct-10-24 08:13AM
Oct-07-24 04:05PM
Sep-21-24 07:31AM
Aug-02-24 03:22AM
Aug-01-24 09:30AM
07:15AM
06:19AM
06:00AM
Jul-25-24 07:00AM
Jul-11-24 08:00AM
Jul-01-24 04:05PM
Jun-18-24 06:28AM
Jun-04-24 06:00AM
May-29-24 09:31AM
May-15-24 04:56PM
May-01-24 10:48AM
09:39AM
08:16AM
03:23AM
01:03AM
Oaktree Specialty Lending Corp., is a closed-end investment fund, which engages in the provision of credit solutions to companies with limited access to public or syndicated capital markets. Its objective is to generate current income and capital appreciation by providing companies with solutions including first and second lien loans, unsecured and mezzanine loans, and preferred equity. The company was founded on February 15, 2007 and is headquartered in Los Angeles, CA.
CEO & Co-Chief Investment OfficerMr. Armen Panossian J.D.
PresidentMr. Mathew M. Pendo
Managing Director & Co-Portfolio Manager of Life Sciences Direct LendingDr. Aman Kumar M.D.
CFO & TreasurerMr. Christopher McKown
Chief Operating OfficerMr. Brett McKeone
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CALDWELL PHYLLIS RDirectorMar 16 '26Buy10.772,50026,92523,500Mar 18 04:05 PM
Gero Deborah AnnDirectorMar 16 '26Buy10.782,00021,55824,411Mar 18 06:05 AM
CALDWELL PHYLLIS RDirectorSep 15 '25Buy13.193,00039,57621,000Sep 16 04:05 PM